381 related articles for article (PubMed ID: 15158547)
1. Botulinum toxin-B and the management of hyperhidrosis.
Baumann LS; Halem ML
Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
Dessy LA; Fallico N; Mazzocchi M; Scuderi N
Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
Yamauchi PS; Lowe NJ
Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
[TBL] [Abstract][Full Text] [Related]
5. Contraindications and complications with the use of botulinum toxin.
Klein AW
Clin Dermatol; 2004; 22(1):66-75. PubMed ID: 15158548
[TBL] [Abstract][Full Text] [Related]
6. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial.
Baumann L; Slezinger A; Vujevich J; Halem M; Bryde J; Black L; Duncan R
Dermatol Surg; 2003 May; 29(5):508-15. PubMed ID: 12752519
[TBL] [Abstract][Full Text] [Related]
7. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
8. Expanding use of botulinum toxin.
Bhidayasiri R; Truong DD
J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
[TBL] [Abstract][Full Text] [Related]
10. Update on the botulinum neurotoxins.
Carruthers A; Carruthers J
Skin Therapy Lett; 2001 Dec; 6(13):1-2. PubMed ID: 11813096
[TBL] [Abstract][Full Text] [Related]
11. [Botulinum toxin. Development for therapeutic purposes].
Ceballos-Baumann A
Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum toxin in the treatment of focal hyperhidrosis].
Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
[TBL] [Abstract][Full Text] [Related]
13. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
Lowe NJ; Shah A; Lowe PL; Patnaik R
J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin type B--a rapid wrinkle reducer.
Jacob CI
Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type B (Myobloc).
Baumann L; Black L
Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
17. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes.
Glogau RG
Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968
[TBL] [Abstract][Full Text] [Related]
18. Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections.
Dubow J; Kim A; Leikin J; Cumpston K; Bryant S; Rezak M
Mov Disord; 2005 Jul; 20(7):877-80. PubMed ID: 15806568
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review.
Campanati A; Diotallevi F; Radi G; Martina E; Marconi B; Bobyr I; Offidani A
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828461
[TBL] [Abstract][Full Text] [Related]
20. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
Carruthers A; Carruthers J; Flynn TC; Leong MS
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
